Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2986582 | The Journal of Thoracic and Cardiovascular Surgery | 2008 | 10 Pages |
Abstract
To our knowledge, this is the first study to examine concomitant substrate modification in patients undergoing new biosurgical therapies by using vascular endothelial growth factor angiogenesis. The results suggest safety and efficacy. Concomitant endothelial modulation with L-arginine not only has the potential to make angiogenesis effective but also may have implications for cell therapy trials.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Marc MD, MPH, Robert S. MD, Mireille PhD, Vincent MD, Nancy RN, Robert A. PhD, Erik J. PhD, Fraser D. MD, Jean N. PhD, Frank W. MD, Duncan J. MD, Thierry G. MD, PhD,